Potential Mediators Between Fibromyalgia and C-Reactive Protein: Results from a Large U.S. Community Survey

Overview

Journal BMC Musculoskelet Disord

Publisher Biomed Central

Specialties Orthopedics
Physiology

Date 2017 Jul 9

PMID 28687081

Citations 15

Authors

Termeh Feinberg

Usha Sambamoorthi

Christa Lilly

Kim Karen Innes

Affiliations

Soon will be listed here.

Abstract

Background: Fibromyalgia, a potentially debilitating chronic pain syndrome of unknown etiology, may be characterized by inflammation. In this study, we investigated the relation of FMS to serum C-reactive protein (CRP) in a large population of adults (18+) and investigated the influence of other factors on this relationship, including BMI, comorbidities, as well as mood and sleep disturbance.

Methods: Participants were 52,535 Ohio Valley residents (Fibromyalgia n = 1125). All participants completed a comprehensive health survey (2005-2006) part of the C8 Health Project; serum levels of CRP were obtained, as was history of Fibromyalgia physician diagnosis. Logistic and linear regressions were used for this cross-sectional analysis.

Results: Mean CRP was higher among participants reporting Fibromyalgia than those without (5.54 ± 9.8 vs.3.75 ± 7.2 mg/L, p < .0001)). CRP level showed a strong, positive association with FMS (unadjusted odds ratio (OR) for highest vs. lowest quartile = 2.5 (CI 2.1,3.0;p for trend < .0001)); adjustment for demographic and lifestyle factors attenuated but did not eliminate this association (AOR for highest vs. lowest quartile = 1.4 (CI 1.1,1.6;p for trend < .0001)). Further addition of body mass index (BMI) and comorbidities to the model markedly weakened this relationship (AORs, respectively, for highest vs lowest CRP quartile = 1.2 (CI 1.0,1.4) and 1.1 (CI 0.9,1.3). In contrast, inclusion of mood and sleep impairment only modestly reduced the adjusted risk estimate (AORs for highest vs. lowest quartile = 1.3 (CI 1.1,1.5) for each)).

Conclusions: Findings from this large cross-sectional study indicate a significant positive cross-sectional association of Fibromyalgia to serum C-reactive protein may be explained, in part, by BMI and comorbidity. Prospective research is needed to confirm this, and clarify the potential mediating influence of obesity and comorbid conditions on this relationship.

Citing Articles

Proinflammatory diet is associated with higher pain, disease severity and biochemical parameters associated with inflammation in fibromyalgia.

Ersoy Soke N, Inceoz H, Solmaz I, Yardimci H Pain Med. 2024; 26(3):131-139.

PMID: 39565919 PMC: 11879218. DOI: 10.1093/pm/pnae118.

Extended Follow-Up and Analysis of Non-secretory IgG-Type Multiple Myeloma in a Patient With Fibromyalgia: A Case Report.

Ohta R, Naito Y, Sano C Cureus. 2024; 16(6):e63321.

PMID: 39070404 PMC: 11283369. DOI: 10.7759/cureus.63321.

Elevated high sensitive C-reactive protein in fibromyalgia.

Beiner E, Brenner Miguel S, Friederich H, Tesarz J Front Psychiatry. 2023; 14:1237518.

PMID: 38098640 PMC: 10720424. DOI: 10.3389/fpsyt.2023.1237518.

C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians.

Mouliou D Diseases. 2023; 11(4).

PMID: 37873776 PMC: 10594506. DOI: 10.3390/diseases11040132.

Development and efficacy evaluation of a personalised self-care programme for reducing work-related musculoskeletal disorders among rubber farmers in Thailand.

Chokprasit P, Yimthiang S, Veerasakul S Heliyon. 2023; 9(10):e20664.

PMID: 37842618 PMC: 10570579. DOI: 10.1016/j.heliyon.2023.e20664.

References

White K, Speechley M, Harth M, Ostbye T . The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol. 1999; 26(7):1570-6. View

Kaufmann I, Schelling G, Eisner C, Richter H, Beyer A, Krauseneck T . Decrease in adhesion molecules on polymorphonuclear leukocytes of patients with fibromyalgia. Rheumatol Int. 2008; 29(9):1109-11. DOI: 10.1007/s00296-008-0803-5. View

Staud R . Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011; 13(6):513-20. DOI: 10.1007/s11926-011-0206-6. View

Aronson D, Bartha P, Zinder O, Kerner A, Markiewicz W, Avizohar O . Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord. 2004; 28(5):674-9. DOI: 10.1038/sj.ijo.0802609. View

Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B . Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?. Rheumatol Int. 2003; 25(3):188-90. DOI: 10.1007/s00296-003-0427-8. View

Mork P, Vasseljen O, Nilsen T . Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Trøndelag Health Study. Arthritis Care Res (Hoboken). 2010; 62(5):611-7. DOI: 10.1002/acr.20118. View

Sanchez del Rio-Gonzalez M . [Chronic migraine: pathophysiology]. Rev Neurol. 2012; 54 Suppl 2:S13-9. View

Martinez-Jauand M, Sitges C, Femenia J, Cifre I, Gonzalez S, Chialvo D . Age-of-onset of menopause is associated with enhanced painful and non-painful sensitivity in fibromyalgia. Clin Rheumatol. 2013; 32(7):975-81. DOI: 10.1007/s10067-013-2212-8. View

Goesling J, Brummett C, Meraj T, Moser S, Hassett A, Ditre J . Associations Between Pain, Current Tobacco Smoking, Depression, and Fibromyalgia Status Among Treatment-Seeking Chronic Pain Patients. Pain Med. 2015; 16(7):1433-42. PMC: 4765172. DOI: 10.1111/pme.12747. View

10.

Tietjen G, Brandes J, Peterlin B, Eloff A, Dafer R, Stein M . Allodynia in migraine: association with comorbid pain conditions. Headache. 2009; 49(9):1333-44. DOI: 10.1111/j.1526-4610.2009.01521.x. View

11.

DellOsso L, Bazzichi L, Baroni S, Falaschi V, Conversano C, Carmassi C . The inflammatory hypothesis of mood spectrum broadened to fibromyalgia and chronic fatigue syndrome. Clin Exp Rheumatol. 2015; 33(1 Suppl 88):S109-16. View

12.

Frisbee S, Brooks Jr A, Maher A, Flensborg P, Arnold S, Fletcher T . The C8 health project: design, methods, and participants. Environ Health Perspect. 2010; 117(12):1873-82. PMC: 2799461. DOI: 10.1289/ehp.0800379. View

13.

Okifuji A, Bradshaw D, Olson C . Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Rheumatol. 2009; 28(4):475-8. PMC: 2668698. DOI: 10.1007/s10067-009-1094-2. View

14.

Metyas S, Solyman J, Arkfeld D . Inflammatory Fibromyalgia: Is it Real?. Curr Rheumatol Rev. 2015; 11(1):15-17. DOI: 10.2174/1573397111666150522095004. View

15.

Wolfe F, Michaud K, Li T, Katz R . Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. J Rheumatol. 2010; 37(2):305-15. DOI: 10.3899/jrheum.090781. View

16.

Ozgocmen S, Cimen O, Ardicoglu O . Relationship between chest expansion and respiratory muscle strength in patients with primary fibromyalgia. Clin Rheumatol. 2002; 21(1):19-22. DOI: 10.1007/s100670200005. View

17.

Amel Kashipaz M, Swinden D, Todd I, Powell R . Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clin Exp Immunol. 2003; 132(2):360-5. PMC: 1808704. DOI: 10.1046/j.1365-2249.2003.02149.x. View

18.

Yang T, Chen C, Lin C, Lin W, Kuo C, Kao C . Risk for irritable bowel syndrome in fibromyalgia patients: a national database study. Medicine (Baltimore). 2015; 94(10):e616. PMC: 4602473. DOI: 10.1097/MD.0000000000000616. View

19.

Fok E, Sandeman S, Guildford A, Martin Y . The use of an IL-1 receptor antagonist peptide to control inflammation in the treatment of corneal limbal epithelial stem cell deficiency. Biomed Res Int. 2015; 2015:516318. PMC: 4330955. DOI: 10.1155/2015/516318. View

20.

Kao T, Lu I, Liao K, Lai H, Loh C, Kuo H . Associations between body mass index and serum levels of C-reactive protein. S Afr Med J. 2009; 99(5):326-30. View